Evaluation of the Effect of Chicory Inulin-type Fructans in Constipated Adults

July 1, 2022 updated by: Sensus

A Randomized Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of Chicory Inulin-type Fructans in Adults With Functional Constipation

Constipation is common in the general population, especially in women and in the elderly, which can significantly affect quality of life of the individual. There is a general consumer trend to seek natural food options, also when addressing health issues such as constipation. Consumers seek tasty options and there is a paucity of tasty functional foods to address constipation. Adding natural fiber to food, like inulin-type fructans from chicory root fiber, can increase fiber intake and potentially prevent or resolve constipation issues. This study aimed to increase the body of scientific data on inulin-type fructans by way of a randomized, placebo-controlled, cross-over study. Maltodextrin was used as the placebo in this study.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Able to give written informed consent
  • Between 18 and 75 years of age
  • Have functional constipation according to the Rome III Diagnostic Criteria
  • Subjects were to continue on their normal diet and agreed to not take probiotic or prebiotic products/supplements and supplemental dietary fibres for the duration of the study
  • The subject agrees to complete the Patient Diary for two weeks prior to study entry and for the duration of the study
  • Subject is in general good health as determined by the investigator.

Exclusion Criteria:

  • Subjects less than 18 and greater than 75 years of age
  • Females who are pregnant, lactating or wish to become pregnant during the study.
  • Subjects who are hypersensitive to any of the components of the test product,
  • Subjects who have an obstructive or metabolic aetiology for constipation,
  • Subjects who have a history of laxative abuse (greater than the daily dosage recommended on the label for any laxative),
  • Subjects currently taking supplemental dietary fibres or have taken them within two weeks of the screening visit,
  • Subjects who are taking a probiotic or prebiotic product/supplement or had taken them within two weeks of the screening visit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Chicory inulin-type fructan - placebo
Dietary supplement: chicory inulin-type fructan Placebo: maltodextrin
Dietary supplement: chicory inulin-type fructan
Experimental: Placebo - chicory inulin-type fructan
Placebo: maltodextrin Dietary Supplement: chicory inulin-type fructan
Dietary supplement: chicory inulin-type fructan

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in stool frequency
Time Frame: During the 12 week intervention period
Determine the impact of chicory inulin-type fructan on stool frequency in constipated subjects.
During the 12 week intervention period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in stool consistency
Time Frame: During the 12 week intervention period
Determine the effect of chicory inulin-type fructans on stool consistency in constipated subjects.
During the 12 week intervention period
Patient Assessment of Constipation Symptoms
Time Frame: During the 12 week intervention period
Determine the effect of chicory inulin-type fructans on constipation symptoms using the Patient Assessment of Constipation Symptoms (PAC-SYM) questionnaire.
During the 12 week intervention period
Quality of life using the PAC-QOL questionnaire
Time Frame: During the 12 week intervention period
Determine the effect of chicory inulin-type fructans on quality of life using the PAC-QOL questionnaire
During the 12 week intervention period
Physical activity
Time Frame: During the 12 week intervention period
Determine the physical activity of the subjects using the International Physical Activity Questionnaire (IPAQ)
During the 12 week intervention period
Resort to laxatives
Time Frame: During the 12 week intervention period
Determine the resort to laxatives of the subjects
During the 12 week intervention period
Gut microbiota composition
Time Frame: During the 12 week intervention period
Determine the effect of chicory inulin-type fructans on gut microbiota composition
During the 12 week intervention period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Elaine E Vaughan, PhD, Sensus BV

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2015

Primary Completion (Actual)

July 28, 2016

Study Completion (Actual)

July 28, 2016

Study Registration Dates

First Submitted

June 28, 2022

First Submitted That Met QC Criteria

July 1, 2022

First Posted (Actual)

July 7, 2022

Study Record Updates

Last Update Posted (Actual)

July 7, 2022

Last Update Submitted That Met QC Criteria

July 1, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AFCRO-058

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Constipation - Functional

Clinical Trials on chicory inulin-type fructan

3
Subscribe